Real Estate Weekly Outlook
The "tech wreck" dragged on as U.S. equity markets declined for the second-straight week, pressured by the previously-high-flying technology sector after Congress failed to reach a compromise on a renewed coronavirus relief bill. The choppiness was further fueled by a potential setback in the vaccine race as AstraZeneca (AZN) temporarily paused its Phase 3 clinical trials while investor attention turned to concerning coronavirus trends outside the United States as the "center of the pandemic" returns to Western Europe amid a reacceleration in case counts in France, U.K.,